D Abigerges

1.1k total citations
12 papers, 827 citations indexed

About

D Abigerges is a scholar working on Oncology, Molecular Biology and Neurology. According to data from OpenAlex, D Abigerges has authored 12 papers receiving a total of 827 indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Oncology, 8 papers in Molecular Biology and 3 papers in Neurology. Recurrent topics in D Abigerges's work include Cancer therapeutics and mechanisms (8 papers), Lung Cancer Research Studies (7 papers) and Neutropenia and Cancer Infections (4 papers). D Abigerges is often cited by papers focused on Cancer therapeutics and mechanisms (8 papers), Lung Cancer Research Studies (7 papers) and Neutropenia and Cancer Infections (4 papers). D Abigerges collaborates with scholars based in France, United States and Belgium. D Abigerges's co-authors include Patrice Herait, G G Chabot, Jean‐Pierre Armand, Daniel Gandía, Alain Gouyette, P. Armand, M. Mahjoubi, R. Bugat, Élie Fadel and Claudia Côté and has published in prestigious journals such as Journal of Clinical Oncology, JNCI Journal of the National Cancer Institute and Cancer Research.

In The Last Decade

D Abigerges

12 papers receiving 800 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
D Abigerges France	8	669	607	120	89	79	12	827
Daniel Gandía France	9	504 0.8×	427 0.7×	140 1.2×	101 1.1×	43 0.5×	14	682
Timothy M. Lestingi United States	11	560 0.8×	599 1.0×	179 1.5×	35 0.4×	24 0.3×	26	844
Yasuyoshi Kawato Japan	9	647 1.0×	830 1.4×	89 0.7×	63 0.7×	35 0.4×	11	1.1k
Kohei Nishio Japan	13	405 0.6×	259 0.4×	139 1.2×	185 2.1×	58 0.7×	46	661
JHM Schellens Netherlands	12	448 0.7×	412 0.7×	72 0.6×	55 0.6×	7 0.1×	16	626
Yan‐jun Mi China	10	424 0.6×	331 0.5×	185 1.5×	66 0.7×	28 0.4×	15	700
Liwei Chen United States	15	239 0.4×	429 0.7×	142 1.2×	43 0.5×	32 0.4×	38	730
Ronald Drengler United States	13	487 0.7×	296 0.5×	104 0.9×	38 0.4×	10 0.1×	27	701
N Saijo Japan	15	531 0.8×	425 0.7×	230 1.9×	60 0.7×	9 0.1×	48	877
Setsuo Takeda Japan	14	575 0.9×	347 0.6×	367 3.1×	145 1.6×	48 0.6×	41	991

Countries citing papers authored by D Abigerges

Since Specialization

Citations

This map shows the geographic impact of D Abigerges's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by D Abigerges with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites D Abigerges more than expected).

Fields of papers citing papers by D Abigerges

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by D Abigerges. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by D Abigerges. The network helps show where D Abigerges may publish in the future.

Co-authorship network of co-authors of D Abigerges

This figure shows the co-authorship network connecting the top 25 collaborators of D Abigerges. A scholar is included among the top collaborators of D Abigerges based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with D Abigerges. D Abigerges is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

12 of 12 papers shown

Damaraju, Sambasivarao, Karen A. Gelmon, José Á. García-Sáenz, et al.. (2016). Abstract P1-13-03: Genome wide association study (GWAS) of genetic variants associated with docetaxel toxicity in the ROSE/TRIO-012 trial. Cancer Research. 76(4_Supplement). P1–13. 1 indexed citations

Abigerges, D, et al.. (2006). Efficacy of erlotinib in the treatment of patients with brain metastasis from non small cell lung cancer. Journal of Clinical Oncology. 24(18_suppl). 17149–17149. 2 indexed citations

Merrouche, Yacine, Jean Marc Extra, D Abigerges, et al.. (1997). High dose-intensity of irinotecan administered every 3 weeks in advanced cancer patients: a feasibility study.. Journal of Clinical Oncology. 15(3). 1080–1086. 48 indexed citations

Chabot, G G, Jean‐Pierre Armand, C. Terret, et al.. (1996). Etoposide bioavailability after oral administration of the prodrug etoposide phosphate in cancer patients during a phase I study.. Journal of Clinical Oncology. 14(7). 2020–2030. 23 indexed citations

Armand, Jean‐Pierre, et al.. (1996). Rationale for the dosage and schedule of CPT-11 (irinotecan) selected for phase II studies, as determined by European phase I studies. Annals of Oncology. 7(8). 837–842. 29 indexed citations

Abigerges, D, Jean‐Pierre Armand, Guy G. Chabot, et al.. (1996). Phase I and pharmacology study of intoplicine (RP 60475; NSC 645008), a novel topoisomerase I and II inhibitor, in cancer patients. Anti-Cancer Drugs. 7(2). 166???174–166???174. 1 indexed citations

Abigerges, D, G G Chabot, Jean‐Pierre Armand, et al.. (1995). Phase I and pharmacologic studies of the camptothecin analog irinotecan administered every 3 weeks in cancer patients.. Journal of Clinical Oncology. 13(1). 210–221. 249 indexed citations

Chabot, G G, D Abigerges, G. Catimel, et al.. (1995). Population pharmacokinetics and pharmacodynamics of irinotecan (CPT-11) and active metabolite SN-38 during phase I trials. Annals of Oncology. 6(2). 141–151. 149 indexed citations

Armand, Jean‐Pierre, Michel Ducreux, M. Mahjoubi, et al.. (1995). CPT-11 (Irinotecan) in the treatment of colorectal cancer. European Journal of Cancer. 31(7-8). 1283–1287. 97 indexed citations

10.

Abigerges, D, P. Armand, G G Chabot, et al.. (1994). Irinotecan (CPT-11) High-Dose Escalation Using Intensive High-Dose Loperamide to Control Diarrhea. JNCI Journal of the National Cancer Institute. 86(6). 446–449. 215 indexed citations

11.

Abigerges, D, Jean‐Pierre Armand, P Rougier, et al.. (1993). High dose intensity of CPT-11 administered as single dose every 3 weeks: The instittut gustave roussy experience. European Journal of Cancer. 29. S118–S118. 12 indexed citations

12.

Abigerges, D, et al.. (1993). Phase I study of the distamycin derivative FCE 24517. European Journal of Cancer. 29. S120–S120. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact